Contained use refers to the use of physical barriers, or the combined use of physical barriers, to limit contact between the GMO and the environment and to provide protection for the general public.
Navigate through the links below to read about Deliberate release and GMO's.
Contained Use of GMOs (i.e. GM Plants)
Annual Report for the contained use of Genetically Modified Organisms (GMOs) (i.e. GM Plants) for 2020
EPA published reports and guidance documents on Licensing & Permitting: GMO's: Alpha 1 antitrypsin.
EPA published reports and guidance documents on Licensing & Permitting: GMO's: Angina Trial.
EPA published reports and guidance documents on Licensing & Permitting: GMO's: Gene therapy administration.
GMO stands for Genetically Modified Organism. It is an organism whose genetic material or DNA has been altered to contain a piece of DNA or gene from another unrelated organism. GMO is defined in the legislation as ‘an organism in which the genetic material is altered in a way that does not occur naturally by mating and/or natural recombination’. Modern recombinant DNA technology enables the ‘stitching together’ of pieces of DNA, regardless of the source of the pieces. Where GMOs include bacteri
Any individual or company using a GMO must obtain consent from the EPA. The EPA is responsible for licensing GMO activities for the: Contained use of GMOs, Deliberate release of GMOs and Transboundary movement of GMOs